Concepedia

Francis Baumgartner

FB

5

Publications

448

Citations

5

H-Index

2014

Active since

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Heidelberg University

German Cancer Research Center

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

Max Delbrück Center

Francis Baumgartner is an author at Charité - Universitätsmedizin Berlin specializing in medicine, tumor biology, and cancer research.

ORCID

Top concepts

Publications per year

2014–2023

5

Publications

5

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 283 citations · Full text

, , +7

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

Uta M. Demel, Marlitt Böger, Schayan Yousefian et al. · Journal of Clinical Investigation · 2022 · 75 citations · Full text

, , +16

SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer

Kerstin Rönsch, Sabine Jägle, Katja Rose et al. · Molecular Oncology · 2014 · 41 citations · Full text

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma

Guus J.J.E. Heynen, Francis Baumgartner, Michael Heider et al. · Blood Advances · 2022 · 31 citations · Full text

, , +13

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022

Francis Baumgartner, Constance Baer, Stefanos A. Bamopoulos et al. · Blood · 2023 · 18 citations · Full text

, , +25

Rows per page

1–5 of 5